Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Regulated Protein Degradation

Regulated Protein Degradation

It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...

Regulated Protein Degradation

Regulated Protein Degradation

Protein Kinases and Phosphatases

Protein Kinases and Phosphatases

Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...

Protein Kinases and Phosphatases

Protein Kinases and Phosphatases

Proteins: From Genes to Degradation

Proteins: From Genes to Degradation

Within a biological system, the DNA encodes the RNA, and the nucleotide sequence in the RNA further defines the amino acid sequence in the protein. This is referred to as “The Central Dogma of Molecular Biology” - a term coined by Francis Crick. Central dogma is a firm principle in biology that defines the flow of genetic information within any life form. The two fundamental steps in central dogma are - transcription and translation.
Transcription is the synthesis of RNA...

Proteins: From Genes to Degradation

Proteins: From Genes to Degradation

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Discovery of Potent and Selective BCL6 Ligand-Directed Degrader (LDD), BCL6-760.

Journal of medicinal chemistry·2025

Same author

Molecular glue CELMoD compounds are regulators of cereblon conformation.

Science (New York, N.Y.)·2022

Same author

Structure of the human marker of self 5-transmembrane receptor CD47.

Nature communications·2021

Same author

Profiling CELMoD-Mediated Degradation of Cereblon Neosubstrates.

Methods in molecular biology (Clifton, N.J.)·2021

Same author

Avadomide induces degradation of ZMYM2 fusion oncoproteins in hematologic malignancies.

Blood cancer discovery·2021

Same author

Multiple cereblon genetic changes are associated with acquired resistance to lenalidomide or pomalidomide in multiple myeloma.

Blood·2021

Search research articles

Related Experiment Video

Updated: Jan 27, 2026

High-Throughput Cellular Profiling of Targeted Protein Degradation Compounds Using HiBiT CRISPR Cell Lines

High-Throughput Cellular Profiling of Targeted Protein Degradation Compounds Using HiBiT CRISPR Cell Lines

Published on: November 9, 2020

Targeted Protein Degradation for Kinase Selectivity.

Philip P Chamberlain¹

¹Celgene Corporation, 10300 Campus Point Drive, Suite 100, San Diego, CA 92121, USA.

Cell Chemical Biology

|March 23, 2019

Summary

This summary is machine-generated.

Researchers developed targeted protein degraders for CDK6, inspired by existing CDK4/6 inhibitors. This novel therapeutic strategy shows potential for treating acute myeloid leukemia.

More Related Videos

Kinase Inhibitor Screening In Self-assembled Human Protein Microarrays

Kinase Inhibitor Screening In Self-assembled Human Protein Microarrays

Published on: October 23, 2019

Assaying Protein Kinase Activity with Radiolabeled ATP

Assaying Protein Kinase Activity with Radiolabeled ATP

Published on: May 26, 2017

Related Experiment Videos

Last Updated: Jan 27, 2026

High-Throughput Cellular Profiling of Targeted Protein Degradation Compounds Using HiBiT CRISPR Cell Lines

High-Throughput Cellular Profiling of Targeted Protein Degradation Compounds Using HiBiT CRISPR Cell Lines

Published on: November 9, 2020

Kinase Inhibitor Screening In Self-assembled Human Protein Microarrays

Kinase Inhibitor Screening In Self-assembled Human Protein Microarrays

Published on: October 23, 2019

Assaying Protein Kinase Activity with Radiolabeled ATP

Assaying Protein Kinase Activity with Radiolabeled ATP

Published on: May 26, 2017

Area of Science:

Drug discovery and development
Chemical biology
Oncology

Background:

Targeted protein degradation is a promising therapeutic strategy.
Cyclin-dependent kinases (CDKs) are key regulators of the cell cycle.
CDK4/6 inhibitors are clinically approved for certain cancers.

Purpose of the Study:

To identify selective degraders of CDK6.
To explore the therapeutic potential of CDK6 degraders.
To investigate a novel approach for acute myeloid leukemia (AML) treatment.

Main Methods:

Derivatization of clinically approved CDK4/6 inhibitors.
Screening for selective CDK6 degradation.
Evaluation of degrader efficacy.

Main Results:

Selective CDK6 degraders were identified.
The identified degraders were derived from existing CDK4/6 inhibitors.
This approach may offer a differentiated therapeutic profile.

Conclusions:

Targeted degradation of CDK6 is achievable using modified CDK4/6 inhibitors.
This strategy holds potential for treating hematological malignancies like AML.
Further research may lead to novel therapeutics for acute myeloid leukemia.